Qualified Research Expenditures Incurred in New York

Qualified Research Expenditures (QREs) incurred in New York represent the state-sourced portion of federal research costs, encompassing internal wages, supplies, and computing expenses directly attributable to innovation activities conducted within the physical boundaries of the state. These expenditures serve as the primary metric for calculating refundable tax incentives under the Life Sciences and Excelsior Jobs programs, provided they satisfy both federal scientific standards and state-specific nexus requirements.

The legal architecture governing these expenditures is a sophisticated hybrid of federal statutory definitions and New York State administrative mandates. At its core, the state leverages the Internal Revenue Code (IRC) Section 41 definition of “qualified research” to ensure that subsidized activities are technologically rigorous and aim to eliminate technical uncertainty through a process of experimentation. However, New York significantly modifies these federal baselines by imposing a strict geographic nexus—requiring that the economic activity and the resulting technical advancement occur within the state—while also selectively excluding certain federal categories, such as contract research, in specific program tracks like the Life Sciences R&D Tax Credit.

The Statutory Definition of Qualified Research Expenditures in New York

The primary legal reference for what constitutes a Qualified Research Expenditure in New York is the federal standard provided in Section 41(b) of the Internal Revenue Code. New York State law adopts this definition to maintain administrative consistency, yet the phrase “incurred in New York” acts as a critical filter that restricts eligibility to the portion of those costs tied to local operations.

The Federal Baseline: IRC Section 41(b)

Under the federal framework, QREs are generally the sum of in-house research expenses and a percentage of contract research expenses. In-house research expenses are subdivided into three categories: wages for qualified services, supplies used in research, and the cost of leasing computers used for research. To be deemed “qualified research” in the first instance, the activity must meet the “Four-Part Test” established by the IRS, which New York revenue offices strictly enforce during the certification process.

Test Component	Narrative and Requirement
Permitted Purpose	The activity must relate to a new or improved business component’s function, performance, reliability, or quality.
Elimination of Uncertainty	The research must aim to discover information that would eliminate technical uncertainty regarding the capability, method, or design of the business component.
Process of Experimentation	The taxpayer must evaluate one or more alternatives through a systematic process, such as modeling, simulation, or trial and error.
Technological in Nature	The process must fundamentally rely on principles of physical or biological sciences, engineering, or computer science.

Defining “Incurred in New York”

The “incurred in New York” requirement is the mechanism by which the state ensures its tax dollars are reinvested locally. For an expense to be considered incurred in the state, there must be a direct physical nexus between the expenditure and the state’s borders.

For wages, this means the employee must physically perform the qualified services within New York State. If an employee performs R&D activities at a facility in Rochester, their wages are eligible. If that same employee performs R&D at a facility in New Jersey, those wages must be excluded, regardless of where the company is headquartered. For supplies, the rule of thumb is the “location of use”. Materials, chemicals, or prototypes must be consumed or utilized in a New York-based laboratory or facility. Computer leasing or rental costs are similarly sourced to the location where the research activity utilizing that computing power is actually conducted.

Categorization of Eligible Expenditures

Understanding the specific nuances of each expenditure category is vital for accurate reporting and maximizing the available credits. New York revenue guidance provides detailed instructions on what can and cannot be included in the QRE base.

Wage Expenditures and the 80% Rule

Wages typically constitute the largest portion of any R&D credit claim. In the context of New York credits, wages include all remuneration paid to an employee for “qualified services,” which are defined as:

• Direct Engagement: The actual performance of research (e.g., a scientist conducting a lab experiment).
• Direct Supervision: The immediate management of those conducting the research (e.g., a lab manager overseeing scientific protocols).
• Direct Support: Activities that assist the research, such as cleaning lab equipment or compiling experimental data.

A significant administrative convenience recognized by New York is the “80% Rule”. If an employee spends at least 80% of their working time performing qualified services in New York, 100% of their annual wages may be treated as New York QREs. If their time spent on R&D in the state falls below this threshold, the taxpayer must perform a “fractional allocation,” including only the specific portion of wages corresponding to the time spent on qualified services within New York.

Supply Costs and Direct Use

Supplies are defined as any tangible property, other than land or improvements to land and property of a character subject to the allowance for depreciation, that is used in the conduct of qualified research. New York guidance, particularly through Sales Tax Bulletin ST-121, emphasizes that these items must be used “directly and predominantly” (more than 50% of the time) in the actual research and development work.

Eligible Supplies	Ineligible Supplies
Lab reagents and chemicals	Land and land improvements
Prototype materials	Depreciable equipment
Testing kits and specialized tools	General administrative supplies
Materials consumed in trial runs	Desks and chairs for clerical staff

Computer Leasing and Cloud Computing

As research increasingly relies on digital modeling and high-performance computing, the “computer rental” category has become more prominent. Eligible costs include amounts paid for the right to use computers in the conduct of qualified research. In the modern era, New York revenue offices interpret this to include hosting costs for off-premise computers and cloud-based processing power, provided the software development or data analysis being performed is part of a qualified New York-based research project.

The Life Sciences Research and Development Tax Credit Program

The Life Sciences R&D Tax Credit is a highly focused program administered by Empire State Development (ESD) and the Department of Taxation and Finance. It is designed to bolster New York’s position as a global leader in biotechnology and pharmaceuticals.

Eligibility and the “New Business” Requirement

To claim this credit, a company must be a “qualified life sciences company” and, crucially, a “new business”. A qualified life sciences company is one that devotes the majority of its efforts to research, development, technology transfer, or commercialization in fields such as agricultural biotechnology, biopharmaceuticals, genomics, medical devices, or medical nanotechnology.

The “new business” test is stringent and designed to prevent existing large corporations from simply spinning off departments to claim the credit:

1. Ownership Test: If the applicant is a corporation, no more than 50% can be owned or controlled by another New York taxpayer.
2. Similarity Test: The applicant must not be “substantially similar” in ownership and operation to another company that is or was previously a New York taxpayer.
3. Duration Test: The applicant must not have been a taxpayer in New York for more than five years prior to the date it applies for the program.

Calculation and Tiered Rates

The Life Sciences credit is calculated as a fixed percentage of the total New York QREs for the tax year. Unlike the federal credit, which is incremental (measuring the increase over a base amount), the New York Life Sciences credit provides a flat return on every dollar of eligible spend in the state.

Company Size (Employees in NY)	Credit Rate (% of NY QREs)
Fewer than 10 Employees	20%
10 or More Employees	15%

The credit is capped at $500,000 per year per taxpayer (or combined group) and has a lifetime cap of $1.5 million. It can be claimed for a maximum of three consecutive years.

The Strict Exclusion of Contract Research

One of the most critical nuances of the Life Sciences program is that “qualified research expenditures” do not include contract research expenses. This is a departure from federal law and from the Excelsior program. For life sciences firms, payments to outside laboratories, universities, or Contract Research Organizations (CROs) are ineligible for the credit, even if those third parties are located in New York. This exclusion forces companies to prioritize building in-house lab capacity and hiring direct employees within the state.

The Excelsior Research and Development Tax Credit Component

The Excelsior Jobs Program is New York’s flagship economic development initiative, offering five fully refundable credits over a 10-year benefit period. Its R&D component is structured differently from the Life Sciences credit, relying on a “percentage-of-federal” model.

Calculation Methodology

The Excelsior R&D credit is equal to 50% of the portion of the federal R&D tax credit that relates to the participant’s research and development expenditures in New York State. This amount is then subject to an upper cap based on a percentage of the total New York research expenditures.

Project Classification	Maximum State Credit (% of NY Expenditures)
Standard Strategic Project	6%
Semiconductor Supply Chain Project	7%
Green Project / Green CHIPS	8%

The 2009 Federal “Freeze” Clause

To ensure stability in the state’s budget and provide certainty to businesses, the New York Economic Development Law contains a “freeze” provision. If the federal R&D tax credit (IRC § 41) were to expire, the research expenditures for the Excelsior credit would still be calculated as if the federal credit structure and definitions that were in effect in 2009 were still in force. This protects New York businesses from federal legislative shifts and ensures a consistent calculation of QREs for state purposes.

Eligibility and Strategic Industries

Participants in the Excelsior program must operate predominantly in specific strategic industries and meet rigorous job creation or investment thresholds.

Industry	Minimum Net New Jobs for Eligibility
Scientific R&D	5 Jobs
Software Development	5 Jobs
Manufacturing	5 Jobs
Agriculture	5 Jobs
Financial Services	25 Jobs
Life Sciences (Non-R&D specific track)	5 Jobs

Qualified Emerging Technology Company (QETC) Credits

The QETC framework is another vital pillar of New York’s innovation tax policy, specifically targeting smaller, high-growth technology firms with annual product sales of $10 million or less.

The R&D Intensity Test

To qualify as a QETC, a company must meet one of two criteria: its primary products or services must be in defined emerging technology fields (e.g., nanotechnologies, remanufacturing, advanced materials), or it must meet a specific R&D intensity ratio. The intensity test requires the company’s ratio of research funds to net sales to equal or exceed the average ratio for all companies surveyed by the National Science Foundation (NSF). Historically, this ratio has hovered around 3.8% to 6%, depending on the survey year and industry classification.

QETC Credit Components

The QETC program offers three distinct tax credit components, two of which are based on research expenditures and property:

• Research and Development Property Credit: A credit of 18% of the cost of R&D property (as defined in IRC § 179(d)) acquired and placed in service in New York during the tax year.
• Qualified Research Expense Credit: A credit of 9% of the QREs paid or incurred by the business during the tax year.
• High-Technology Training Credit: A 100% credit for the cost of training employees at degree-granting New York institutions in subjects related to emerging technologies, capped at $4,000 per employee.

Local State Revenue Office Guidance and Compliance

Successful utilization of these credits depends on adherence to the procedural guidance issued by Empire State Development (ESD) and the New York State Department of Taxation and Finance (DTF).

The Certification and Application Process

Unlike federal credits, which are typically “self-certified” on a tax return, New York R&D credits require an upfront application and formal certification from ESD.

1. The Consolidated Funding Application (CFA): For most programs, businesses must apply through the CFA portal. ESD reviews the application for alignment with the state’s economic goals.
2. Certificate of Eligibility: If approved, the business is admitted into the program and receives a Preliminary Schedule of Benefits.
3. Performance Report: Within 30 days of the end of each tax year, the business must submit a performance report to ESD demonstrating that it met its job or expenditure targets.
4. Certificate of Tax Credit: Once verified, ESD issues a formal Certificate of Tax Credit. This certificate is the “golden ticket”—it specifies the exact amount of credit that can be claimed on the tax return.

Tax Filing Requirements

The credit is claimed by filing specific forms with the taxpayer’s New York State return. For the Life Sciences credit, corporations use Form CT-648, while individuals (including partners and S-corp shareholders) use Form IT-648. For the Excelsior program, corporations use Form CT-607.

Taxpayers must attach a copy of the ESD Certificate of Tax Credit to their return. Failing to enter the exact certificate number or credit amount listed on the ESD document can lead to an immediate denial of the credit.

Refundability and Ordering of Credits

Both the Life Sciences and Excelsior R&D credits are fully refundable. This means that the credit can reduce the business’s tax liability to the statutory minimum (the “fixed dollar minimum tax”), and the state will issue a check for the excess as a tax refund.

Program	Refundable?	Carryforward?
Life Sciences R&D	Yes	No; excess is refunded immediately
Excelsior Jobs Program	Yes	No; excess is refunded immediately
QETC Credits	Yes	Varied; check component specifics

Nuances of the “Incurred in New York” Nexus for Remote Workers

In the post-pandemic economy, the definition of where research is “incurred” has become a central focus for state auditors. New York’s “Convenience of the Employer” rule plays a critical role here.

The Convenience Rule and R&D Wages

The convenience rule states that if a nonresident employee is assigned to a New York office but works from home in another state for their own convenience (rather than employer necessity), their wages are sourced to New York for personal income tax purposes. However, there is a technical tension between this rule and the R&D credit statute. For R&D credit purposes, the statute typically requires that the qualified services be performed in the state.

State revenue guidance and recent Tax Appeals Tribunal decisions suggest that while the wages may be subject to New York withholding under the convenience rule, they may still fail to qualify as New York QREs if the scientific work was not physically conducted within the state’s borders. To avoid credit recapture or audit adjustments, businesses must maintain detailed records of the employee’s physical work location and, if possible, document the “employer necessity” for any out-of-state work (e.g., use of specialized equipment located in another jurisdiction).

Illustrative Examples and Multi-Year Scenarios

Practical application of these rules requires balancing multiple program requirements.

Example 1: New Biotech Startup (Life Sciences Program)

“AlphaBio Tech” is a newly formed C-Corp in Long Island with 6 employees. In 2024, it spends $2 million on NY QREs:

• $1.4M on scientist wages (all NY-based)
• $400k on lab supplies
• $200k on cloud computing for genomic sequencing

Calculation:

Because AlphaBio has fewer than 10 employees, it qualifies for the 20% rate.

Total Credit = $2,000,000 \times 20% = $400,000.

Since $400,000 is below the $500k annual cap, the full amount is allowed. If the company’s New York tax liability is only $1,000, it would receive a refund check for $399,000.

Example 2: Green Technology Firm (Excelsior Program)

“SolarGrid Systems” is an established manufacturing firm in Buffalo that has been accepted into the Excelsior Jobs Program as a “Green Project.” In 2024, its federal R&D tax credit (Form 6765) is $500,000. Of the underlying expenditures, 60% were incurred in New York. Its total New York research expenditures for the year were $4 million.

Calculation:

1. Federal Portion: $500,000 \times 60% = $300,000.
2. Base State Credit: $300,000 \times 50% = $150,000.
3. Cap Check: As a Green Project, the cap is 8% of NY expenditures. $4,000,000 \times 8% = $320,000.
4. Allowable Credit: Since the base credit ($150,000) is less than the cap ($320,000), the firm is issued a certificate for $150,000.

Statistical Insights into the New York R&D Tax Landscape

Official reports from Empire State Development provide a clear picture of the program’s utility and economic impact.

Metric	Life Science Initiative (Through Oct 2023)
Total R&D Credits Issued	$18.2 Million
Total Qualified Expenses Reported	$34.68 Million (in 2022-23 period)
Growth in Life Science Sector Jobs	18.5% (2017-2022)
Growth in Life Science Companies	27.1% (2017-2022)
NIH Funding Received in NY	$3.6 Billion

New York currently ranks #2 in the nation for R&D spend by publicly traded life science companies and #3 in the nation for the highest number of bioscience patents issued. These statistics suggest that the “incurred in New York” requirement has been effective in anchoring high-value R&D activity within the state despite global competition.

Documentation and Audit Retention Standards

The Department of Taxation and Finance requires that all documentation supporting a credit claim be “contemporaneous”—meaning it must be created at the time the expense is incurred or the research is performed.

The Technical Narrative

Taxpayers should maintain a “Technical Narrative” for each research project that aligns with the Four-Part Test. This narrative must highlight the technical challenges faced and the specific experimental methods (e.g., trial and error, modeling) used to solve them.

The Documentation Checklist

State auditors typically request the following documents during a review of R&D credits:

• Payroll Records: Documentation linking specific employee time to research projects.
• Lab Notes/Logs: Dated records of experiments, failures, and successes.
• Photos and Videos: Visual evidence of various stages of assembly, build, or testing.
• Prototype Documentation: Invoices for materials and records of how the prototype was utilized in testing.
• Contracts: For Excelsior projects, copies of third-party contracts to verify the U.S.-based location and financial risk of the taxpayer.

Records must be maintained for at least three years after the return is filed, although many tax professionals recommend a seven-year retention period to align with potential federal audits.

Interaction with Federal Tax Reform (Section 174 Amortization)

A significant development for New York R&D taxpayers is the federal requirement to capitalize and amortize R&D costs over five years (domestic) or 15 years (foreign) under IRC § 174, which began in 2022.

New York State generally conforms to the federal tax base. This means that for state corporate franchise tax purposes, businesses can no longer deduct their full R&D spend in the first year. However, New York Advisory Opinion 24-13i provides critical relief for resident partners and S-corp shareholders. It clarifies that while the entity must add back the payroll expenses used to calculate the R&D credit (to avoid a double benefit), the individual partners are allowed a “subtraction modification” on their personal New York returns for their share of those disallowed wages. This preserves the value of the R&D credit for small, pass-through entities.

Future Outlook and Strategic Considerations

New York’s R&D tax credit landscape is increasingly defined by sectoral targeting. The introduction of enhanced credits for “Green Projects,” “Green CHIPS,” and the “Semiconductor Supply Chain” reflects a strategic pivot toward sustainable technologies and domestic manufacturing of critical electronics. For businesses operating in these fields, the state credit can now reach up to 8% of total NY research expenditures—a significant increase over the standard 6% Excelsior cap.

Furthermore, the state continues to invest in laboratory infrastructure, with over 3.1 million square feet of lab space now available in New York City alone. This physical infrastructure, combined with the 20% refundable credit for small life sciences firms, creates a powerful ecosystem for “pre-revenue” innovation.

Final Thoughts

The meaning of Qualified Research Expenditures Incurred in New York extends far beyond a simple accounting of lab costs. It represents a strict legal and geographic standard that demands a rigorous nexus between innovation and local economic participation. While the state leverages the federal IRC § 41 definition of “qualified research” as its scientific foundation, the subsequent filters—geographic sourcing of wages, the exclusion of contract research in the life sciences track, and the reliance on ESD certification—create a unique and local compliance environment.

For businesses, the primary challenge lies in the dual burden of proof: satisfying the federal Four-Part Test to ensure technical eligibility while simultaneously satisfying New York’s nexus rules to ensure geographic eligibility. The rewards for doing so are substantial—fully refundable credits that can reach up to 20% of in-state spend and benefit periods that can extend to a full decade. As the state continues to expand its support for “Green” and “Semiconductor” technologies, the strategic importance of accurately identifying and documenting New York QREs will only grow. In an era of remote work and globalized supply chains, the “incurred in New York” requirement stands as a vital policy tool for ensuring that the state remains a premier destination for the world’s most advanced research and development.